Method of the Year 2009
-
Biotechnology
-
36+ votes
26- votes
- Log in to vote
-
Development of an Inhibitor Screening Platform via Mass Spectrometry
- Original article citation: Journal of Biomolecular Screening 13," 1007 - 1013, (2008).
- Categories: Biotechnology, Protein biochemistry, and Proteomics
- Recommended by: Rakesh Rathore on 08/20/2009 05:19PM GMT
- Reasons for recommending:
-MALDI-QqQMS readout is a direct measurement of the substrate and the product, this readout eliminates false positive and false negative inhibitor in HTS. -Provides comparable speeds, with superior signal-to-background, better reproducibility and a reagent cost of about 3 cents per well versus 60 cents per well for the fluorescent readout. -Have a real potential of opening an entirely new service application to the Drug Discovery research.
-
Comments
Reader comments are usually moderated after posting. For more controversial topics, we reserve the right to moderate before comments are published.
Add your own comment
You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Remember this is for feedback and discussion - not for publishing papers, press releases or advertisements, for example.
You need to be registered with Nature to leave a comment. Please log in or register as a new user. You will be re-directed back to this page.

It appears to be a wonderful , quick and cost effective method in the area of enzyme kinectics for studying inhibition.
New generation matrix-assisted laser desorption ionization-triple quadrupole mass spectrometer (MALDI-QqQMS), is ideally suited for a variety of enzyme assays and screening protocols. This readout provides comparable speeds (at greater than a sample per second) with superior signal-to-background, better reproducibility and a reagent cost of about 3 cents per well versus 60 cents per well for the fluorescent readout system. Importantly, since the MALDI-QqQMS readout is a direct measurement of the substrate and the product (the essences of an enzyme assay) this readout eliminates false positive and false negative inhibitor hits that can plague fluorescence and chemiluminescent systems that often rely on coupled enzyme assays as the readout. The importance of this work to HTS community is the real potential of opening an entirely new service application to the Drug Discovery research in industrial and academic environment and MALDI-QqQMS platform could change the way the industry does High throughput screening.
Please check our recent paper on MS based High throughput Screening: Rathore R, Corr JJ, Lebre DT, Seibel WL, Greis KD . Extending MALDI-QqQ MS Enzyme Screening Assays to Targets with Small Molecule Substrates. Rapid Commun Mass Spectrom; 2009 Sep;23(20):3293-3300. http://www3.interscience.wiley.com/journal/122597719/abstract?CRETRY=1&SRETRY=0